- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-1-mer
- Ligands
- 22 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 23 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.23: 2 residues within 4Å:- Chain A: N.17, N.135
Ligand excluded by PLIPNAG.24: 2 residues within 4Å:- Chain A: Y.28, N.61
Ligand excluded by PLIPNAG.25: 3 residues within 4Å:- Chain A: E.130, N.159, N.160
Ligand excluded by PLIPNAG.26: 5 residues within 4Å:- Chain A: F.335, D.336, F.339, N.340, N.367
Ligand excluded by PLIPNAG.27: 4 residues within 4Å:- Chain A: A.703, E.1069, K.1070, N.1071
Ligand excluded by PLIPNAG.28: 3 residues within 4Å:- Chain A: N.613, T.615, Q.641
Ligand excluded by PLIPNAG.29: 4 residues within 4Å:- Chain B: N.17, L.18, R.21, D.136
Ligand excluded by PLIPNAG.30: 2 residues within 4Å:- Chain B: Y.28, N.61
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain B: N.120, A.121, T.122
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain B: Q.113, N.159, N.160
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain B: T.106, N.231
Ligand excluded by PLIPNAG.34: 3 residues within 4Å:- Chain B: N.277, E.278, N.279
Ligand excluded by PLIPNAG.35: 2 residues within 4Å:- Chain B: N.328, Q.577
Ligand excluded by PLIPNAG.36: 5 residues within 4Å:- Chain B: F.339, N.340, V.364, N.367, L.368
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain B: N.613, Q.641
Ligand excluded by PLIPNAG.38: 1 residues within 4Å:- Chain C: N.17
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain C: Y.28, N.61
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain C: N.120, T.122, V.125
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain C: N.159, N.160
Ligand excluded by PLIPNAG.42: 5 residues within 4Å:- Chain B: K.459, E.462
- Chain C: T.106, N.231, T.233
Ligand excluded by PLIPNAG.43: 3 residues within 4Å:- Chain C: N.328, Q.577, L.579
Ligand excluded by PLIPNAG.44: 4 residues within 4Å:- Chain C: D.336, F.339, N.340, L.368
Ligand excluded by PLIPNAG.45: 1 residues within 4Å:- Chain C: N.613
Ligand excluded by PLIP- 1 x ZN: ZINC ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhao, Z. et al., Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escape. Nat Commun (2022)
- Release Date
- 2022-09-21
- Peptides
- Spike glycoprotein: ABC
Processed angiotensin-converting enzyme 2: D - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-1-mer
- Ligands
- 22 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 23 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x ZN: ZINC ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhao, Z. et al., Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escape. Nat Commun (2022)
- Release Date
- 2022-09-21
- Peptides
- Spike glycoprotein: ABC
Processed angiotensin-converting enzyme 2: D - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D